1. Home
  2. VKTX vs FMC Comparison

VKTX vs FMC Comparison

Compare VKTX & FMC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VKTX
  • FMC
  • Stock Information
  • Founded
  • VKTX 2012
  • FMC 1910
  • Country
  • VKTX United States
  • FMC United States
  • Employees
  • VKTX N/A
  • FMC N/A
  • Industry
  • VKTX Biotechnology: Pharmaceutical Preparations
  • FMC Major Chemicals
  • Sector
  • VKTX Health Care
  • FMC Industrials
  • Exchange
  • VKTX Nasdaq
  • FMC Nasdaq
  • Market Cap
  • VKTX 7.2B
  • FMC 8.0B
  • IPO Year
  • VKTX 2015
  • FMC N/A
  • Fundamental
  • Price
  • VKTX $49.58
  • FMC $54.39
  • Analyst Decision
  • VKTX Strong Buy
  • FMC Hold
  • Analyst Count
  • VKTX 10
  • FMC 14
  • Target Price
  • VKTX $109.80
  • FMC $68.00
  • AVG Volume (30 Days)
  • VKTX 6.8M
  • FMC 1.3M
  • Earning Date
  • VKTX 10-23-2024
  • FMC 10-29-2024
  • Dividend Yield
  • VKTX N/A
  • FMC 4.26%
  • EPS Growth
  • VKTX N/A
  • FMC 195.29
  • EPS
  • VKTX N/A
  • FMC 11.60
  • Revenue
  • VKTX N/A
  • FMC $4,167,899,999.00
  • Revenue This Year
  • VKTX N/A
  • FMC N/A
  • Revenue Next Year
  • VKTX N/A
  • FMC $4.53
  • P/E Ratio
  • VKTX N/A
  • FMC $4.46
  • Revenue Growth
  • VKTX N/A
  • FMC N/A
  • 52 Week Low
  • VKTX $10.51
  • FMC $50.03
  • 52 Week High
  • VKTX $99.41
  • FMC $68.72
  • Technical
  • Relative Strength Index (RSI)
  • VKTX 31.07
  • FMC 28.33
  • Support Level
  • VKTX $62.50
  • FMC $55.11
  • Resistance Level
  • VKTX $70.41
  • FMC $61.58
  • Average True Range (ATR)
  • VKTX 5.16
  • FMC 2.33
  • MACD
  • VKTX -2.29
  • FMC -0.87
  • Stochastic Oscillator
  • VKTX 1.99
  • FMC 1.04

About VKTX Viking Therapeutics Inc.

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

About FMC FMC Corporation

FMC is a pure-play global crop protection company with a fairly balanced product portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop protection companies and focuses on the development of new products, including biologicals, through its research and development pipeline.

Share on Social Networks: